January 11, 2023

Prenetics Owned ACT Genomics Receives FDA Clearance for ACTOnco, the First Asia-Based Company to Receive Clearance for a Comprehensive Genomic Profiling Test for All Solid Tumors

LONDON AND HONG KONG, Jan 11, 2023 – (ACN Newswire via SEAPRWire.com) – Prenetics Global Limited (NASDAQ: PRE) a leader in genomic and diagnostic testing,…

September 9, 2022

Dammam Valley and Arcensus GmbH to establish Saudi-German Genomic Center in Riyadh

DAMMAM, SAUDI ARABIA, Sep 8, 2022 – (ACN Newswire via SEAPRWire.com) – Dammam Valley, in partnership with other investment partners, and Arcensus GmbH announce the…

September 6, 2022

Dammam Valley/KSA to acquire the majority of Arcensus GmbH/Germany to accelerate the global implementation of Whole Genome Sequencing in genetic diagnostics and delivery of breakthrough technologies in genomic bioinformatics

ROSTOCK, Germany & DAMMAM, KSA, Sep 5, 2022 – (ACN Newswire via SEAPRWire.com) – Dammam Valley in partnership with other investment partners, announce to acquire…

January 12, 2022

Arcensus has appointed Prof. Dr. Arndt Rolfs as New CEO

Hoboken, NJ, Rostock & Berlin, Germany, Jan 12, 2022 – (ACN Newswire via SEAPRWire.com) – Arcensus, a commercial-stage digital healthcare and diagnostics company that empowers…

October 19, 2021

Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment

TOKYO, Oct 19, 2021 – (JCN Newswire via SEAPRWire.com) – Aichi Cancer Center (1) and Fujitsu Limited today announced the development of an AI solution…